The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aker Christopher Ray since 2019.
This trader's CIK number is 1762611.
At the time of last reporting, Aker Christopher Ray was the Sr. VP & General Counsel of Regulus Therapeutics Inc.. (stock ticker symbol RGLS).
Also see all insider trading activities at Regulus Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RGLS | 0 | $0 | 5,468 | $6,512 | 0 | $0 |
| 2021 | RGLS | 0 | $0 | 828 | $1,424 | 0 | $0 |
| 2020 | RGLS | 0 | $0 | 5,784 | $4,454 | 0 | $0 |
| 2019 | RGLS | 0 | $0 | 15,963 | $18,006 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-18 | RGLS | Sale | 5,468 | 1.19 | 6,512 |
| 2021-02-16 | RGLS | Sale | 828 | 1.72 | 1,424 |
| 2020-11-16 | RGLS | Sale | 876 | .52 | 456 |
| 2020-08-14 | RGLS | Sale | 872 | .60 | 527 |
| 2020-05-15 | RGLS | Sale | 909 | .63 | 569 |
| 2020-02-18 | RGLS | Sale | 888 | .83 | 737 |
| 2020-01-02 | RGLS | Sale | 2,239 | .97 | 2,165 |
| 2019-11-14 | RGLS | Sale | 833 | .64 | 533 |
| 2019-10-01 | RGLS | Sale | 2,346 | .68 | 1,602 |
| 2019-08-15 | RGLS | Sale | 899 | .55 | 495 |
| 2019-07-01 | RGLS | Sale | 2,225 | 1.31 | 2,919 |
| 2019-05-15 | RGLS | Sale | 6,950 | 1.41 | 9,799 |
| 2019-04-01 | RGLS | Sale | 2,710 | .98 | 2,658 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aker Christopher Ray (Sr. VP & General Counsel of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.